Trial intelligence / Profile preview

Sildenafil and Group Psychotherapy for Psychogenic Erectile Dysfunction

NCT01153204Phase 4Completed

Sponsor
Federal University of São Paulo
Modality
Small Molecules
01

Overview

Phase 4, randomised, single-blind trial of sildenafil in psychogenic erectile dysfunction (PED) (3 arms), sponsored by Federal University of São Paulo. Primary endpoint: Satisfaction with the treatment at 9 months. Status: completed.

02

Drugs

sildenafil
03

Conditions

psychogenic erectile dysfunction (PED)

Beyond the preview

Go deeper on NCT01153204.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01153204.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call